ADAMTS13 Protein

• 

  Subject Areas on Research

  • ASFA Category IV becomes Category I: Idiopathic thrombotic thrombocytopenic purpura in a patient with presumed gemcitabine-induced thrombotic microangiopathy. 
  • Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura. 
  • Is it quinine TTP/HUS or quinine TMA? ADAMTS13 levels and implications for therapy. 
  • Novel therapeutic approaches for thrombotic thrombocytopenic purpura. 
  • Relapse of thrombotic thrombocytopenic purpura: is it a continuum of disease? 
  • Thrombotic thrombocytopenic purpura: 2012 American Society for Apheresis (ASFA) consensus conference on classification, diagnosis, management, and future research. 
  • Ticlopidine- and clopidogrel-associated thrombotic thrombocytopenic purpura (TTP): review of clinical, laboratory, epidemiological, and pharmacovigilance findings (1989-2008). 
  • Ticlopidine-associated ADAMTS13 activity deficient thrombotic thrombocytopenic purpura in 22 persons in Japan: a report from the Southern Network on Adverse Reactions (SONAR).